NYSE:TDOCTeladoc Health Stock Price, Forecast & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 52.9% and is now trading at $210.09. View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

Teladoc Health Inc (NYSE:TDOC) announced its quarterly earnings data on Wednesday, April, 29th. The health services provider reported ($0.40) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.05. The health services provider had revenue of $180.80 million for the quarter, compared to analyst estimates of $180.64 million. Teladoc Health had a negative return on equity of 10.60% and a negative net margin of 16.24%. Teladoc Health's revenue was up 40.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.43) EPS. View Teladoc Health's earnings history.

Teladoc Health issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided EPS guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

24 brokers have issued 1-year price objectives for Teladoc Health's stock. Their forecasts range from $80.00 to $220.00. On average, they anticipate Teladoc Health's stock price to reach $161.17 in the next twelve months. This suggests that the stock has a possible downside of 23.3%. View analysts' price targets for Teladoc Health.

News headlines about TDOC stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Teladoc Health earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Teladoc Health.

Some companies that are related to Teladoc Health include Takeda Pharmaceutical (TAK), Illumina (ILMN), Humana (HUM), Boston Scientific (BSX), Baxter International (BAX), Biogen (BIIB), Edwards Lifesciences (EW), Siemens Healthineers (SHL), LONZA GRP AG/ADR (LZAGY), DexCom (DXCM), Centene (CNC), RESMED/IDR UNRESTR (RMD), COLOPLAST A/S/ADR (CLPBY), HCA Healthcare (HCA) and ASTELLAS PHARMA/ADR (ALPMY). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $210.09.

Teladoc Health has a market capitalization of $15.64 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

The official website for Teladoc Health is www.teladoc.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]